Exchange: NASDAQ
Industry: Pharmaceuticals & Biotechnology
Last Trade: 4:00 PM ET 4/5/2013
Last 10 Quotes:
What's This?
Earnings vs. Expectations
Compare| Mar 2012* | Jun 2012* | Sep 2012* | Dec 2012* | Mar 2013* | |
| * Quarter Ending | |||||
|---|---|---|---|---|---|
| Estimated EPS($) | 0.39 | 0.36 | 0.48 | 0.53 | 0.60 |
| Reported EPS($) | 0.45 | 0.47 | 0.60 | 0.60 | NA |
| GAAP($) | 0.23 | 0.18 | 0.46 | NA | NA |
| Mar 2013* | Jun 2013* | Dec 2013** | Dec 2014** | |
| * Quarter Ending ** Fiscal Year Ending | ||||
| Average Estimate ($) | 0.60 | 0.68 | 2.89 | 3.33 |
| Number of Analysts | 18 | 18 | 22 | 21 |
| Low Estimate ($) | 0.55 | 0.63 | 2.80 | 2.75 |
| High Estimate ($) | 0.67 | 0.74 | 3.12 | 3.80 |
| Mar 2013* | Jun 2013* | Dec 2013** | Dec 2014** | |
| * Quarter Ending ** Fiscal Year Ending | ||||
|---|---|---|---|---|
| Current Estimate ($) | 0.60 | 0.68 | 2.89 | 3.33 |
| 30 Days Ago ($) | 0.60 | 0.68 | 2.89 | 3.33 |
| 90 Days Ago ($) | 0.61 | 0.66 | 2.82 | 3.26 |
| Dec 2013* | Dec 2014* | Next 3 Years (per year) | Forward P/E | PEG | ||
| * Year Ending | ||||||
|---|---|---|---|---|---|---|
| ALXN | 57.69% | 41.07% | 26.31% | 34.48 | 0.97 | |
